G

ood morning, everyone, and welcome to another working week. We hope the weekend respite was invigorating and refreshing, because that ever-demanding routine of meetings, deadlines, and the like has returned. Our routine, however, will be slightly different for the next few days as we bop around the J.P. Morgan Healthcare Conference. Nonetheless, we are still accepting tips and foraging for interesting items. On that note, here are some tidbits. Hope you have a smashing day and do stay in touch …

Teva Pharmaceuticals was chastised by Wall Streeters for lowering its financial guidance once again, “further eroding what, in our view, was already limited management credibility,” according to Piper Jaffray analyst David Amsellem. And he called for a “major” management overhaul after noting the core generics business and brand-name drug business are overdue for a pick-me-up, especially as its all-important Copaxone multiple sclerosis drug faces generic competition.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • Stadium food hawkers are hired based on their ability to fling a bag of peanuts across 40 seats to the guy at the end of the row. Now if he can fling the Epipen with the same accuracy he will be promoted.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy